Rhenman & Partners Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Rhenman & Partners Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-213,901	Closed	-$5.36M	–	116
2017 Q2	$5.36M	Buy	213,901 +60,000	+39%	+$1.49M	0.77%	52
2017 Q1	$4.13M	Sell	153,901 -5,000	-3%	-$138K	0.65%	57
2016 Q4	$4.17M	Buy	158,901 +13,601	+9%	+$336K	0.8%	49
2016 Q3	$3.63M	Hold	145,300	–	–	0.58%	62
2016 Q2	$3.15M	Buy	+145,300	New	+$2.59M	0.56%	62

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Rhenman & Partners Asset Management's NXTM Position: Q3 2017 in Review

Rhenman & Partners Asset Management sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 213,901 shares — an estimated $5.36M sold.

Rhenman & Partners Asset Management first reported a position in NXTM in Q2 2016 and held it in 5 quarters. The position peaked at $5.36M in Q2 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

Rhenman & Partners Asset Management reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
Rhenman & Partners Asset Management sold 213,901 NxStage Medical Inc. shares in Q3 2017, an estimated $5.36M.
Rhenman & Partners Asset Management first reported a position in NxStage Medical Inc. in Q2 2016 and held it in 5 quarters.
Rhenman & Partners Asset Management's NxStage Medical Inc. position peaked at $5.36M in Q2 2017.
168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.